MHRA Field Safety Notices September 2026: Key Device Alerts Issued

• The MHRA published Field Safety Notices (FSNs) for medical devices between September 21 and 25, 2026.
• Recipients of FSNs from manufacturers are legally obligated to act on the information provided.
• Notices cover various devices, including electrosurgical equipment, implantable pulse generators, PACS software, wheelchairs, MRI units, and intraocular lenses.
• The MHRA acts as an information publisher, directing specific inquiries about FSNs to the respective manufacturers.
• Failure to comply with FSNs can lead to significant regulatory penalties and product liability risks for UK medical device stakeholders.

If a field safety notice is received directly from a manufacturer, it is imperative that the recipient always acts upon it.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a series of Field Safety Notices (FSNs) covering the period from September 21 to September 25, 2026. These critical alerts pertain to various medical devices, signaling potential safety concerns that require immediate attention from manufacturers, distributors, and healthcare providers operating within the UK. While the MHRA serves as the central publishing authority for these notices, it explicitly states that its role is to disseminate this information, and any questions regarding a specific FSN should be directed to the respective manufacturer.

These MHRA Field Safety Notices September 2026 highlight the ongoing commitment to patient safety and product integrity within the UK medical device sector. The notices encompass a broad spectrum of medical equipment, from surgical instruments to diagnostic software and patient mobility aids, underscoring the diverse nature of potential safety issues that can arise. Stakeholders are reminded that receiving an FSN from a manufacturer necessitates prompt and appropriate action to mitigate risks.

Among the devices identified in the recent MHRA FSN list 2026 are several critical items. For instance, an Endoscopic electrosurgical handpiece/electrode is subject to an alert under MHRA reference 40884402 (2026/009/022/601/105). A related notice, MHRA reference 40915918 (2026/008/012/601/106), specifically concerns an Endoscopic electrosurgical electrode, bipolar, affecting models CD-B610LA, CD-B612LA, CD-B620LA, and CD-B622LA. An Implantable Pulse Generator is also flagged with MHRA reference 40885977 (2026/008/012/601/046).

Further alerts include Radiological PACS software (MHRA reference 40875688, 2026/009/018/601/058) and a range of models under MHRA reference 40915709 (2026/009/024/601/146), specifically IGK0008-40, IGK0008RS15-40SG, IGK0008RS15SG, IGK0008RS20SG, IGK0008RS30SG, IGK0008RS45SG, IGK0008RS60SG, IGKAX0808RS45/20SG, and IGKAX0808RS45/30SG. Other significant UK medical device recalls include an Electric-motor-driven wheelchair, occupant-control (MHRA reference 40900232, 2026/009/011/601/033), a Magnetic Resonance Imaging (MRI) unit (MHRA reference 40863216, 2026/007/020/601/071), and a Lens, Intraocular, Posterior Chamber (MHRA reference 40913437, 2026/009/001/601/156). Additionally, a battery for FRED easy (MHRA reference 40897441, 2026/009/010/601/080) and other Vascular and Cardiac Prostheses (MHRA reference 40918509, 2026/009/025/601/013) are also listed, alongside several other general alerts with specific MHRA references such as 40883311, 40882641, 40820981 (Ref FA00001, models 978A1, 978B1, 3560022, 3560030), 40822960 (Ref FA00006), and 40911343.

For legal professionals and compliance officers advising entities involved in the UK medical device supply chain, these MHRA device safety alerts are not merely informational; they represent a mandatory call to action. If a field safety notice is received directly from a manufacturer, it is imperative that the recipient always acts upon it. Failure to adhere to Field Safety Notice compliance UK can expose organizations to significant regulatory penalties, including fines and operational restrictions, as well as substantial product liability exposure in the event of patient harm.

Therefore, a thorough review of these and other medical product safety warnings UK is essential. Lawyers and compliance teams must ensure their clients, whether manufacturers, distributors, or healthcare providers, are fully aware of these specific notices and are implementing all necessary corrective and preventative actions. This proactive approach is critical for maintaining regulatory standing and safeguarding against potential legal repercussions arising from non-compliance with medical device regulatory updates GB.

Beyond the immediate MHRA Field Safety Notices September 2026, the agency provides comprehensive resources for accessing past safety information. Users can view a complete list of FSNs published since January 2020, offering a broader perspective on recent UK medical device recalls and safety trends. Furthermore, a more extensive archive of FSNs published since November 2014 is also available for review.

For those requiring even older records, FSNs issued prior to November 2014 are maintained and accessible through the National Archives website. This structured approach to information dissemination ensures that all relevant historical data on medical product safety warnings UK remains available for due diligence, risk assessment, and compliance auditing purposes.

Lawyers and compliance officers advising medical device manufacturers, distributors, or healthcare providers in the UK must review these MHRA Field Safety Notices to ensure their clients are aware of and are taking appropriate corrective actions. Failure to act on these notices can lead to significant regulatory penalties and product liability exposure.

Source: Original reporting via GOV.UK